These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 7106010)
21. p53 expression compared with other prognostic factors in OMS grade-I stage-Ta transitional cell carcinoma of the bladder. Casetta G; Gontero P; Russo R; Pacchioni D; Tizzani A Eur Urol; 1997; 32(2):229-36. PubMed ID: 9286659 [TBL] [Abstract][Full Text] [Related]
22. Recurrence, progression and success in stage Ta grade 3 bladder tumors treated with low dose bacillus Calmette-Guerin instillations. Lebret T; Bohin D; Kassardjian Z; Herve JM; Molinie V; Barre P; Lugagne PM; Botto H J Urol; 2000 Jan; 163(1):63-7. PubMed ID: 10604315 [TBL] [Abstract][Full Text] [Related]
23. Urothelial papilloma of the bladder. Clinical and biologic implications. Cheng L; Darson M; Cheville JC; Neumann RM; Zincke H; Nehra A; Bostwick DG Cancer; 1999 Nov; 86(10):2098-101. PubMed ID: 10570437 [TBL] [Abstract][Full Text] [Related]
24. Urothelial (transitional cell) papilloma of the urinary bladder: a clinicopathologic study of 26 cases. McKenney JK; Amin MB; Young RH Mod Pathol; 2003 Jul; 16(7):623-9. PubMed ID: 12861056 [TBL] [Abstract][Full Text] [Related]
25. [Clinical significance of the degree of malignancy in transitional epithelioma of the urinary bladder]. Stöber U Urologe A; 1984 May; 23(3):167-70. PubMed ID: 6539992 [TBL] [Abstract][Full Text] [Related]
26. [Value of exfoliative cytology of the urinary bladder in occult bladder cancer and in the control of treated cancers]. Schmitz A; Meyer U; Kierfeld G; Küchemann K Urologe A; 1984 Sep; 23(5):278-80. PubMed ID: 6542269 [TBL] [Abstract][Full Text] [Related]
27. Relationship between papillary and nodular transitional cell carcinoma in the human urinary bladder. Kakizoe T; Tobisu K; Takai K; Tanaka Y; Kishi K; Teshima S Cancer Res; 1988 Apr; 48(8):2299-303. PubMed ID: 3349494 [TBL] [Abstract][Full Text] [Related]
28. Does the expression of fascin-1 and tumor subclassification help to assess the risk of recurrence and progression in t1 urothelial urinary bladder carcinoma? Soukup V; Babjuk M; Dusková J; Pesl M; Szakáczová M; Zámecník L; Dvorácek J Urol Int; 2008; 80(4):413-8. PubMed ID: 18587253 [TBL] [Abstract][Full Text] [Related]
29. [Superficial grade G2 tumors of the bladder: recurrence, progression, prognosis]. Sebe P; Lebret T; Molinie V; Herve JM; Yonneau L; Lugagne PM; Saporta F; Orsoni JL; Butreau M; Botto H Prog Urol; 2003 Sep; 13(4):608-12. PubMed ID: 14650291 [TBL] [Abstract][Full Text] [Related]
33. The identification and significance of early stromal invasion in papillary carcinomas of the urinary bladder. Tiltman AJ J Pathol; 1977 Jun; 122(2):91-4. PubMed ID: 874643 [TBL] [Abstract][Full Text] [Related]
34. Endoscopic management of upper tract urothelial carcinoma in patients with a history of bladder urothelial carcinoma. Krambeck AE; Thompson RH; Lohse CM; Patterson DE; Segura JW; Zincke H; Elliott DS; Blute ML J Urol; 2007 May; 177(5):1721-6. PubMed ID: 17437796 [TBL] [Abstract][Full Text] [Related]
35. [Prognostic factors in 243 transitional carcinomas of the bladder (II): microscopic parameters of the tumor and staging]. Portillo Martín JA; Val Bernal F; Garijo Ayenza F; Buelta Carrillo L; Martín García B; Hernández Rodríguez R; Gutiérrez Baños JL; Correas Gómez MA; Concepción Masip T; Fernández Gómez JM Arch Esp Urol; 1991 Mar; 44(2):161-8. PubMed ID: 1867491 [TBL] [Abstract][Full Text] [Related]
36. [Frequency of recurrences and tumor progression on superficial bladder carcinoma (author's transl)]. Rübben H; Dahm HH; Lutzeyer W Urologe A; 1981 Jul; 20(4):211-4. PubMed ID: 7196631 [TBL] [Abstract][Full Text] [Related]
37. Relationship of cytokeratin 20 and CD44 protein expression with WHO/ISUP grade in pTa and pT1 papillary urothelial neoplasia. Desai S; Lim SD; Jimenez RE; Chun T; Keane TE; McKenney JK; Zavala-Pompa A; Cohen C; Young RH; Amin MB Mod Pathol; 2000 Dec; 13(12):1315-23. PubMed ID: 11144928 [TBL] [Abstract][Full Text] [Related]
38. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour. Solsona E; Iborra I; Rubio J; Casanova J; Almenar S BJU Int; 2004 Dec; 94(9):1258-62. PubMed ID: 15610101 [TBL] [Abstract][Full Text] [Related]
39. Gene expression profiling of progressive papillary noninvasive carcinomas of the urinary bladder. Wild PJ; Herr A; Wissmann C; Stoehr R; Rosenthal A; Zaak D; Simon R; Knuechel R; Pilarsky C; Hartmann A Clin Cancer Res; 2005 Jun; 11(12):4415-29. PubMed ID: 15958626 [TBL] [Abstract][Full Text] [Related]